WHC est encore en dévelopement. Lisez ceci pour comprendre notre approche.
depiction of SHXWCVYOXRDMCX-UHFFFAOYSA-N.svg
tripsit

mdma

Vérifier sur tripsit

psychonaut

MDMA

Vérifier sur psychonaut

isomerdesign

MDMA

Vérifier sur isomerdesign

isomerdesign

(2S)-1-(2H-1,3-Benzo...

Vérifier sur isomerdesign

isomerdesign

(2R)-1-(2H-1,3-Benzo...

Vérifier sur isomerdesign

pubchem

3,4-Methylenedioxyme...

Vérifier sur pubchem

druglab

MDMA

Vérifier sur druglab

drugmap

Methylenedioxymetham...

Vérifier sur drugmap

wiki

MDMA

Vérifier sur wiki

Data

InChI: InChI=1S/C11H15NO2/c1-8(12-2)5-9-3-4-10-11(6-9)14-7-13-10/h3-4,6,8,12H,5,7H2,1-2H3

Synonymes: EA-1475,C07577,(RS)-1-(BENZO(D)(1,3)DIOXOL-5-YL)-N-METHYLPROPAN-2-AMINE,mandy,N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE,Phenethylamine, N,alpha-dimethyl-3,4-methylenedioxy-,(2R)-1-(1,3-Benzodioxol-5-yl)-N-methylpropan-2-amine,3,4-Methylenedioxy-N,alpha-dimethyl-beta-phenylethylamine,3,4-methylenedioxymetamphetamine,N-Methyl-3,4-methylenedioxyamphetamine,D11172,md,CHEMBL43048,AKOS006283463,(+-)-N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane, (+-)-(3,4-Methylenedioxy)methamphetamine,rac-3,4-Methylenedioxymethamphetamine,Methylenedioxymethamfetamine, (RS)-3,4-(methylenedioxy)methamphetamine,KBio1_000962,MIDOMAFETAMINE [INN],NCGC00168266-01,[1-(1,3-Benzodioxol-5-yl)propan-2-yl](methyl)azan,molly,DTXSID90860791,XTC [Street Name],1-(1,3-Benzodioxol-5-yl)-N-methyl-2-propanamine, Midomafetamine,Mandy [Street Name], N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE,Methylenedioxymethamphetamine,(+/-)-3,4-METHYLENEDIOXYMETHAMPHETAMINE,xtc,Ecstasy, DEA No 7405,XTC,3,4-Methylenedioxymethamphetamine,Midomafetamine [USAN],ecstasy,Q69488,Epitope ID:178091, 42542-10-9,MDMA (unspecified),CCRIS 9277,(+/-)-MDMA solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,MDMA (Ecstasy),3,4-Methylenedioxy-N-methylamphetamine (MDMA),(2S)-1-(1,3-Benzodioxol-5-yl)-N-methylpropan-2-amine,(2R)-1-(2H-1,3-Benzodioxol-5-yl)-N-methylpropan-2-amine,Midomafetamine, Methylenedioxymethamphetamine,MDMA,NCGC00168266-02,(+/-)-N-METHYL-1-(3,4-METHYLENEDIOXYPHENYL)-2-AMINOPROPANE,N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE [HSDB],54946-52-0,PDSP1_001522,(RS)-3,4-(methylenedioxy)methamphetamine,Methylenedioxy Methamphetamine,Molly,3,4-Methylenedioxy-N-methylamphetamine,UNII-KE1SEN21RM, CHEBI:1391,(+/-)-N,.ALPHA.-DIMETHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE,BDBM50010588,(+/-)-(3,4-Methylenedioxy)methamphetamine,MANDY,[1-(2H-1,3-benzodioxol-5-yl)propan-2-yl](methyl)amine,rac-MDMA (rac-3,4-Methylenedioxymethamphetamine) 1.0 mg/ml in Methanol,METHYLENEDIOXYMETHAMFETAMINE [MART.],Methylenedioxymetamphetamine, MDMA (unspecified),MDM,1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine,(+-)-N-Methyl-3,4-(methylenedioxy)amphetamine,D,L-3,4-METHYLENEDIOXYMETHAMPHETAMINE,X,1,3-Benzodioxole-5-ethanamine, N,.alpha.-dimethyl-,42542-10-9,PHENETHYLAMINE, N,.ALPHA.-DIMETHYL-3,4-METHYLENEDIOXY-,3,4-MDMA,3,4-methylenedioxymethamphetamine,MDMA [MI],Midomafetamine [WHO-DD], 1,3-Benzodioxole-5-ethanamine, N,alpha-dimethyl-,GTPL4574,DivK1c_000962,(2S)-1-(2H-1,3-Benzodioxol-5-yl)-N-methylpropan-2-amine,DL-(3,4-Methylenedioxy)methamphetamine, (+-)-N-Methyl-3,4-(methylenedioxy)amphetamine,SCHEMBL44210, DL-(3,4-Methylenedioxy)methamphetamine,x, 1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine,(+-)-(3,4-Methylenedioxy)methamphetamine,NINDS_000962,CHEBI:1391,KE1SEN21RM,ADAM, MDMA,METHYLENEDIOXYMETHAMPHETAMINE [WHO-DD], HSDB 6929,adam,N,alpha-Dimethyl-1,3-benzodioxole-5-ethanamine,3,4-methylenedioxy-n-methylamphetamine,3,4-methylenedioxymethylamphetamine, Ecstasy,Midomafetamine (USAN/INN),DEA No. 7405,DB01454,HSDB 6929, N,alpha-Dimethyl-1,3-benzodioxole-5-ethanamine,(+/-)-N-Methyl-3,4-(methylenedioxy)amphetamine,PDSP2_001506,1,3-Benzodioxole-5-ethanamine, N,alpha-dimethyl-, 3,4-methylenedioxymethamphetamine,IDI1_000962


Estimated data

Solubility: -1.425 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 93.5% (prediction based on www.mdpi.com)

Similitudes

Voici une série de comparaisons visant à comprendre les propriétés de ce composé. Ce site est encore très expérimental et fait l'objet d'un développement actif. Veuillez vous référer à notre série d'articles d'articles pour bien comprendre notre approche et ses limites. Ces informations sont données à titre indicatif et ne doivent pas être interprétées comme des conseils médicaux.